CommentClinical trial registration: transparency is the watchword
References (17)
- et al.
WHO facilitates international collaboration in setting standards for clinical trial registration
Lancet
(2005) Research injury in clinical trials in South Africa
Lancet
(2006)Tragic drug trial spotlights potent molecule
Nature
(2006)- et al.
Expression of concern: Bombardier et al. “Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.” N Engl J Med 2000; 243: 1520–28
N Engl J Med
(2005) Pfizer faulted over drug trials in Nigeria
Washington Post
(May 7, 2006)- et al.
Origin and funding of the most frequently cited papers in medicine: database analysis
BMJ
(2006) Being a modern pharmaceutical company: involves making information available on clinical trial programmes
BMJ
(1998)- et al.
Registering clinical trials
JAMA
(2003)
There are more references available in the full text version of this article.
Cited by (138)
Guidance needed: where should randomized studies which do not assess a health outcome be registered?
2023, Journal of Clinical EpidemiologyPrinciples and applications of metaresearch
2022, Contemporary Research Methods in Pharmacy and Health ServicesMeta-research in pharmacy: Time for a look in the mirror
2021, Research in Social and Administrative PharmacyConservative Interventions Reduce Fear in Individuals With Chronic Low Back Pain: A Systematic Review
2020, Archives of Physical Medicine and RehabilitationAssessment of frequency and reporting of design changes among clinical drug trials published in influential medical journals
2020, European Journal of Internal MedicineAnalysis of the first 2645 registrations at the research registry<sup>®</sup>: A global repository for all study types involving human participants
2018, International Journal of Surgery
Copyright © 2006 Elsevier Ltd. All rights reserved.